Auditors, lawyers, tax consultants and management consultants: Four perspectives. One solution. Worldwide. Find out …
We review your past and advise you on the implementation of future requirements and projects. Find out more!
Our clients entrust us with their most important legal matters. Learn more about our legal services!
Tax laws are complex and dynamic. We face the challenge of tax law together with you - find out more.
We support you with customised solutions so that your company can continue to operate successfully on the market in …
Tax challenges for German companies operating internationally
Deemed Supply Chain: VAT Risks with Third-Country Connections
Pay slips are purely information documents
EU “Omnibus” Package: Less effort for sustainability reporting?
Baker Tilly starts the year 2025 with 23 new Directors
Challenges in corporate finance: Baker Tilly at Structured FINANCE 2024
BAG overturns forfeiture clause for share options after termination
Art. 273a ZPO: More protection for trade secrets in civil proceedings
Baker Tilly advises CFL on container vessel acquisition
Public procurement: Legally compliant procurement of cyber insurance
Countdown to September – The EU Data Act and its implications
Procurement law – legal framework for emergency procurements in the event of a cyberattack
Industry-specific knowledge is essential in order to create the best conditions for customised solutions. Find out …
Baker Tilly advises biotech startup Real Collagen GmbH investment by US investor
Energy study: Uncertainty slows down investments by industry and utilities in Germany
After ECJ ruling: Financial investors still have no direct access to medical care centers
Benefit from bundled interdisciplinary competencies, expert teams and individual solutions. Learn more!
Baker Tilly offers a wide range of individual and innovative consulting services. Find out more!
Find the right partners in order to maximize the value of your products or acquire new licenses. We help you to identify and integrate strategic partners for in- and out-licensing.
The increasing use of in- and out-licensing agreements in the healthcare sector is influenced by various factors. These include the high development costs and risks of new drugs and technologies, the lack of internal expertise and the need to expand the product and patent portfolio.
For biotech and pharmaceutical companies, licensing agreements open up opportunities to gain access to innovative technologies and new markets while reducing financial and organizational risks. This is particularly important in order to remain competitive in a constantly changing industry.
In order to take full advantage of the benefits of in- and out-licensing, it is crucial to deal with the associated challenges.
In-licensing
Out-licensing
Stephan Zuber
Partner
Attorney-at-Law (Rechtsanwalt), Specialist Lawyer for Commercial and Corporate Law
Talk to us - without any obligation
Contact now
View all news